Paper Review Records
All Paper Review Records
10 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
89
days
TNFRSF10D expression as a potential biomarker for cisplatin-induced damage and ovarian tumor relapse prediction
AuthorsNikole Gontijo Gonçales; Bryan Ôrtero Perez Gonçalves; Luciana Maria Silva; Agnaldo Lopes da Silva Filho; Letícia da Conceição Braga
AffiliationsCellular Biology, Research and Development Department, Ezequiel Dias Foundation, Belo Horizonte, Minas Gerais 30510-010, Brazil; Department of General Biology, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais 31270-901, Brazil; Translational Research Laboratory in Oncology, Mário Penna Institute, Belo Horizonte, MG, Brazil; Department of Gynecology and Obstetrics, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais, Brazil
69
days
Intratumoral heterogeneity of oncogenic drivers in mixed histology lung adenocarcinomas: How tissue selection impacts molecular testing?
AuthorsKritika Krishnamurthy; Jiani Chai; Xiaowei Liu; Mahmoud Elsayad; Doctor Y. Goldstein
AffiliationsMontefiore medical Center, Bronx, NY, USA; University of Texas McGovern School of Medicine, TX, USA; Albert Einstein College of Medicine, Bronx, NY, USA
51
days
Focusing on tumor and it's microenvironmental immune members for head and neck cancer patients
AuthorsSaim Pamuk; Baris Ertugrul; Goksu Kasarci; Sinem Bireller; Arzu Ergen; Bedia Cakmakoglu; Murat Ulusan
AffiliationsDepartment of Otorhinolaryngology & Head and Neck Surgery, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey; Department of Molecular Medicine, Aziz Sancar Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey; Graduate School of Health Sciences, Istanbul University, Istanbul, Turkey; Department of Biochemistry, Faculty of Pharmacy, Acibadem Mehmet Ali Aydınlar University, Istanbul, Turkey
74
days
Heterotopic salivary duct inclusions in Warthin tumor – A cryptic histological finding involved in its pathogenesis
AuthorsMasamichi Goto; Kengo Nishimoto; Yasuyo Jougasaki; Tsutomu Matsuzaki; Tomonori Tanaka; Mitsuharu Nomoto
AffiliationsDepartment of Pathology, NHO Kagoshima Medical Center, Kagoshima, Japan; Department of Otorhinolaryngology, NHO Kagoshima Medical Center, Kagoshima, Japan
120
days
Next generation sequence-based targeted somatic mutation analysis in thyroid nodules with pathologically diagnosed as indeterminate cytology
AuthorsGizem Kök; Deniz Nart; Yeşim Ertan; Suha Sureyya Özbek; Ali Mizrak; Özer Makay; Mehmet Erdoğan; Hatice Özışık; Haluk Akın; Burak Durmaz; Su Özgür; Murat Özdemir; Emin Karaca
AffiliationsDepartment of Medical Genetics, Van Educational and Research Hospital, Van, Turkey; Medical Genetics Diagnostic Lab, Department of Medical Genetics, Ege University School of Medicine, İzmir, Turkey; Department of Pathology, Ege University School of Medicine, İzmir, Turkey; Department of Radiology, Ege University School of Medicine, İzmir, Turkey; Department of General Surgery, Ege University School of Medicine, İzmir, Turkey; Division of Endocrinology and Metabolism, Department of Internal Medicine, Ege University School of Medicine, İzmir, Turkey; Department of Biostatistics and Medical Informatics, Ege University School of Medicine, İzmir, Turkey; Ozel Saglik Hospital, Center of Endocrine Surgery, İzmir, Turkey; Aristotle University, School of Medicine, Thessaloniki
19
days
Mesothelin promotes the migration of endometrioid carcinoma and is associated with the MELF pattern
AuthorsShinichiro Tahara; Satoshi Nojima; Tsuyoshi Takashima; Daisuke Okuzaki; Eiichi Morii
AffiliationsDepartment of Pathology, Osaka University Graduate School of Medicine, Osaka, Japan; Single Cell Genomics, Human Immunology, WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan
126
days
Effect of lamins and emerin on nuclear morphology and histological architecture in lung adenocarcinoma
AuthorsSayaka Kobayashi; Yuki Kanehira; Raia Kushibiki; Yoshimi Nishijima; Toshiteru Nagashima; Yoichi Ohtaki; Hayato Ikota; Hideaki Yokoo; Masanao Saio
AffiliationsLaboratory of Histopathology and Cytopathology, Department of Laboratory Sciences, Gunma University Graduate School of Health Sciences, Gunma 371-8514, Japan; Division of General Thoracic Surgery, Integrative Center of General Surgery, Gunma University Hospital; Clinical Department of Pathology, Gunma University Hospital, Gunma 371-8511, Japan; Department of Human Pathology, Gunma University Graduate School of Medicine, Gunma 371-8511, Japan
129
days
Caveolin-1 protects retinal ganglion cells in glaucoma by reducing TLR4 and activating the Akt/PTEN signaling pathway
AuthorsLiwei Zhang; Wen Chu; Xiaoxiao Feng; Juanjuan Li; Yuling Ren; Yabin Yang; Zhikun Zheng; Hua Li
AffiliationsDepartment of Ophthalmology, The Affiliated Hospital of Yunnan University; The Second People's Hospital of Yunnan Province; Yunnan Eye Hospital, Kunming, Yunnan 650021, China; Dental Medicine Center, The Affiliated Hospital of Yunnan University; The Second People's Hospital of Yunnan Province; Yunnan Eye Hospital, Kunming, Yunnan 650031, China
145
days
Cathepsin V is a useful prognostic factor for colorectal cancer
AuthorsMoon-Soo Lee; Chang-Nam Kim; Dong Wook Kang; Joo Heon Kim
AffiliationsDepartment of Surgery, Eulji Medical Center, Daejeon, Republic of Korea; Department of Pathology, Eulji Medical Center, Daejeon, Republic of Korea
212
days
Evaluation of reference genes suitable for studying mRNAs and microRNAs expression in thyroid neoplasms
AuthorsIman Jahanbani; Nada Almoualem; Abeer Al-Abdallah
AffiliationsPathology Department, Faculty of Medicine, Kuwait University, Kuwait
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review96.4 days
Median77 days